Skip to content
OpenCapital
Get started

MiNK Therapeutics, Inc. INKT Q4 2024 Annual earnings

Reported March 18, 2025 · Before market open

EPS-$0.62Miss by $0.12
EPS estimate-$0.50

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.60

Versus estimates

Diluted EPS

Q1 2026-$0.57Beat by $0.20Q4 2025-$0.52Beat by $0.16Q3 2025-$0.65Beat by $0.21Q2 2025-$1.06Miss by $0.51Q1 2025-$0.70Miss by $0.09
Q4 2024-$0.62Miss by $0.12

Ask the moment MiNK Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MiNK Therapeutics, Inc. report Q4 2024 earnings?
MiNK Therapeutics, Inc. (INKT) reported Q4 2024 earnings on March 18, 2025 before market open.
What were MiNK Therapeutics, Inc.'s Q4 2024 revenue and EPS?
MiNK Therapeutics, Inc. reported eps of $-0.62 for Q4 2024.
Did MiNK Therapeutics, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.50 by $0.12.
Where can I find MiNK Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-041379) directly on SEC EDGAR. The filing index links above go to sec.gov.